MutaFrame

MutaFrame predicts the deleteriousness of protein-coding single nucleotide variants (SNVs) in human genomes by integrating molecular effects, protein domain, gene relevance, and interaction data at the protein-structure level.

Key Features:

• DEOGEN2 methodology: Implements the DEOGEN2 algorithm to integrate diverse molecular data for variant impact prediction on protein-coding sequences.
• Data integration: Considers molecular effects of variants, specific protein domains affected, gene biological relevance, and gene interactions in its analyses.
• Non-linear mapping and scoring: Employs a non-linear mapping approach to synthesize heterogeneous inputs into a single deleteriousness score per variant.
• Per-variant deleteriousness score: Produces a quantitative score intended to distinguish deleterious from benign SNVs in human genomes.
• Protein-structure-level interpretation: Interprets variant effects at the protein structure level to inform on potential impacts on protein function.
• High-throughput sequencing compatibility: Operates on variants derived from high-throughput sequencing data.
• Molecular and interaction databases: Leverages extensive molecular information and protein–protein interaction data to provide contextualized predictions.

Scientific Applications:

• Variant prioritization for disease studies: Identifies potentially harmful genetic variants that may contribute to disease.
• Molecular mechanism investigation: Aids understanding of molecular mechanisms underlying variant effects on protein function.
• Individual genetic risk assessment: Supports assessment of individual genetic risks relevant to personalized medicine approaches.

Methodology:

MutaFrame analyzes genomic variants with the DEOGEN2 algorithm to systematically evaluate deleteriousness using extensive molecular and protein–interaction databases.